Erratum to "Microfluidic System Based High Throughput Drug Screening System for Curcumin/Trail Combinational Chemotherapy in Human Prostate Cancer PC3 Cells" (Biomolecules and Therapeutics, (2014), 22, (355-362), 10.4062/biomolther.2014.078);Microfluidic system based high throughput drug screening system for curcumin/TRAIL combinational chemotherapy in human prostate cancer PC3 cells

Biomolecules and Therapeutics

Volumn 22, Issue 4, 2014, Pages 355-362

  An, Dami ^a   Kim, Kwangmi ^a   Kim, Jeongyun ^a  

^a Dankook University   (South Korea)

Author keywords

Combinational chemotherapy; Curcumin; HTDS; Microfluidic system; PC 3; TRAIL

Indexed keywords

CURCUMIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG EXPOSURE; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; MICROFLUIDIC ANALYSIS; PC3 CELL LINE; PROSTATE CANCER CELL LINE;

EID: 84905250780     PISSN: 19769148     EISSN: 20054483     Source Type: Journal    
DOI: 10.4062/biomolther.2014.475     Document Type: Erratum

References (35)

1. Adam, V., Ekblad, M., Sweeney, K., Muller, H., Busch, K. H., Johnsen, C. T., Kang, N. R., Lemoine, N. R. and Hallden, G. (2012) Synergistic and selective cancer cell killing mediated by the oncolytic adenoviral mutant addeltadelta and dietary phytochemicals in prostate cancer models. Hum. Gene Ther. 23, 1003-1015.
2. Aggarwal, B. B., Kumar, A. and Bharti, A. C. (2003) Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 23, 363-398.
3. Amin, A. R., Kucuk, O., Khuri, F. R. and Shin, D. M. (2009) Perspectives for cancer prevention with natural compounds. J. Clin. Oncol. 27, 2712-2725.
4. Barua, S., Linton, R. S., Gamboa, J., Banerjee, I., Yarmush, M. L. and Rege, K. (2010) Lytic peptide-mediated sensitization of TRAILresistant prostate cancer cells to death receptor agonists. Cancer Lett. 293, 240-253.
5. Beltran, H., Beer, T. M., Carducci, M. A., De Bono, J., Gleave, M., Hussain, M., Kelly, W. K., Saad, F., Sternberg, C., Tagawa, S. T. and Tannock, I. F. (2011) New therapies for castration-resistant prostate cancer: efficacy and safety. Eur. Urol. 60, 279-290.
6. Bouralexis, S., Findlay, D. M. and Evdokiou, A. (2005) Death to the bad guys: targeting cancer via Apo2L/TRAIL. Apoptosis 10, 35-51.
7. Deeb, D., Gao, X., Jiang, H., Divine, G., Dulchavsky, S. A. and Gautam, S. C. (2006) Vaccination with leukemia-loaded dendritic cells eradicates residual disease and prevent relapse. J. Exp. Ther. Oncol. 5, 183-193.
8. Deeb, D., Jiang, H., Gao, X., Al-Holou, S., Danyluk, A. L., Dulchavsky, S. A. and Gautam, S. C. (2007) Curcumin [1,7-bis(4-hydroxy-3-methoxyphenyl)-1-6-heptadine-3,5-dione; C21H20O6] sensitizes human prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L-induced apoptosis by suppressing nu clear factor-kappaB via inhibition of the prosurvival Akt signaling pathway. J. Pharmacol. Exp. Ther. 321, 616-625.
9. Deeb, D., Jiang, H., Gao, X., Hafner, M. S., Wong, H., Divine, G., Chapman, R. A., Dulchavsky, S. A. and Gautam, S. C. (2004) Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-kappaB through suppression of IkappaBalpha phosphorylation. Mol. Cancer. Ther. 3, 803-812.
10. Garstecki, P., Fuerstman, M. J., Stone, H. A. and Whitesides, G. M. (2006) Formation of droplets and bubbles in a microfluidic T-junction-scaling and mechanism of break-up. Lab. Chip 6, 437-446.
11. Graf, N. J. and Bowser, M. T. (2013) Effect of cross sectional geometry on PDMS micro peristaltic pump performance: comparison of SU-8 replica molding vs. micro injection molding. Analyst 138, 5791-5800.
12. Heger, M., Van Golen, R. F., Broekgaarden, M. and Michel, M. C. (2014) The molecular basis for the pharmacokinetics and pharmacodynamics of curcumin and its metabolites in relation to cancer. Pharmacol. Rev. 66, 222-307.
13. Hung, P. J., Lee, P. J., Sabounchi, P., Aghdam, N., Lin, R. and Lee, L. P. (2005a) A novel high aspect ratio microfluidic design to provide a stable and uniform microenvironment for cell growth in a high throughput mammalian cell culture array. Lab. Chip 5, 44-48.
14. Hung, P. J., Lee, P. J., Sabounchi, P., Lin, R. and Lee, L. P. (2005b) Continuous perfusion microfluidic cell culture array for high-through put cell-based assays. Biotechnol. Bioeng. 89, 1-8.
15. Kelley, S. K. and Ashkenazi, A. (2004) Targeting death receptors in can cer with Apo2L/TRAIL. Curr. Opin. Pharmacol. 4, 333-339.
16. Kim, J., Hegde, M. and Jayaraman, A. (2010a) Co-culture of epithelial cells and bacteria for investigating host-pathogen interactions. Lab. Chip 10, 43-50.
17. Kim, J., Hegde, M. and Jayaraman, A. (2010b) Microfluidic co-culture of epithelial cells and bacteria for investigating soluble signal-mediated interactions. J. Vis. Exp.
18. Kim, J., Hegde, M., Kim, S. H., Wood, T. K. and Jayaraman, A. (2012a) A microfluidic device for high throughput bacterial biofilm studies. Lab. Chip 12, 1157-1163.
19. Kim, J., Taylor, D., Agrawal, N., Wang, H., Kim, H., Han, A., Rege, K. and Jayaraman, A. (2012b) A programmable microfluidic cell array for combinatorial drug screening. Lab. Chip 12, 1813-1822.
20. Lai, H. and Folch, A. (2011) Design and dynamic characterization of "single-stroke" peristaltic PDMS micropumps. Lab. Chip 11, 336-342.
21. Lee, P. J., Hung, P. J., Rao, V. M. and Lee, L. P. (2006) Nanoliter scale microbioreactor array for quantitative cell biology. Biotechnol. Bioeng. 94, 5-14.
22. Li, N., Hsu, C. H. and Folch, A. (2005) Parallel mixing of photolithographically defined nanoliter volumes using elastomeric microvalve arrays. Electrophoresis 26, 3758-3764.
23. Neils, C., Tyree, Z., Finlayson, B. and Folch, A. (2004) Combinatorial mi xing of microfluidic streams. Lab. Chip 4, 342-350.
24. Ohtsuka, T., Ryu, H., Minamishima, Y. A., Ryo, A. and Lee, S. W. (2003) Modulation of p53 and p73 levels by cyclin G: implication of a negative feedback regulation. Oncogene 22, 1678-1687.
25. Shankar, S., Chen, X. and Srivastava, R. K. (2005) Effects of sequential treatments with chemotherapeutic drugs followed by TRAIL on prostate cancer in vitro and in vivo. Prostate 62, 165-186.
26. Shankar, S., Siddiqui, I. and Srivastava, R. K. (2007) Molecular mechani sms of resveratrol (3,4,5-trihydroxy-trans-stilbene) and its interaction with TNF-related apoptosis inducing ligand (TRAIL) in androgen-insensitive prostate cancer cells. Mol. Cell. Biochem. 304, 273-285.
27. Shankar, S., Singh, T. R. and Srivastava, R. K. (2004) Ionizing radiation enhances the therapeutic potential of TRAIL in prostate cancer in vitro and in vivo: Intracellular mechanisms. Prostate 61, 35-49.
28. Sheikh, M. S. and Fornace, A. J., JR. (2000) Role of p53 family members in apoptosis. J. Cell. Physiol. 182, 171-181.
29. Siddiqui, I. A., Malik, A., Adhami, V. M., Asim, M., Hafeez, B. B., Sarfaraz, S. and Mukhtar, H. (2008) Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis. Oncogene 27, 2055-2063.
30. Simons, J. W., Mikhak, B., Chang, J. F., Demarzo, A. M., Carducci, M. A., Lim, M., Weber, C. E., Baccala, A. A., Goemann, M. A., Clift, S. M., Ando, D. G., Levitsky, H. I., Cohen, L. K., Sanda, M. G., Mulligan, R. C., Partin, A. W., Carter, H. B., Piantadosi, S., Marshall, F. F. and Nelson, W. G. (1999) Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocytemacrophage colony-stimulating factor using ex vivo gene transfer. Cancer Res. 59, 5160-5168.
31. Unger, M. A., Chou, H. P., Thorsen, T., Scherer, A. and Quake, S. R. (2000) Monolithic microfabricated valves and pumps by multilayer soft lithography. Science 288, 113-116.
32. Wang, Z., Kim, M.-C., Marquez, M. and Thorsen, T. (2007) High-density microfluidic arrays for cell cytotoxicity analysis. Lab. Chip 7, 740-745.
33. Whitesides, G. M., Ostuni, E., Takayama, S., Jiang, X. and Ingber, D. E. (2001) Soft lithography in biology and biochemistry. Annu. Rev. Biomed. Eng. 3, 335-373.
34. Wilken, R., Veena, M. S., Wang, M. B. and Srivatsan, E. S. (2011) Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol. Cancer 10, 12.
35. Zhang, L. and Fang, B. (2005) Mechanisms of resistance to TRAILinduced apoptosis in cancer. Cancer Gene Ther. 12, 228-237.